CNBC's Jim Cramer on Tuesday said it may be too soon to tell how GLP-1 diabetes and weight loss drugs will change companies, especially ones that sell junk food.on Tuesday said it may be too soon to tell how GLP-1 diabetes and weight loss drugs will affect the stock of companies like
Walmart said last week it is seeing a"slight change" in food-shopping habits, some of which may be due to customers buying less while using appetite-suppressing medications like diabetes drugs Mounjaro or Wegovy,
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Herkunft: CNBC - 🏆 12. / 72 Weiterlesen »
Herkunft: CNBC - 🏆 12. / 72 Weiterlesen »
Herkunft: NBCDFW - 🏆 288. / 63 Weiterlesen »
Herkunft: nbcchicago - 🏆 545. / 51 Weiterlesen »